Soltamox Related Clinical Trials
Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid [Active, not recruiting]
Tamoxifen in Patients With Oesophageal Cancer [Not yet recruiting]
Tamoxifen Treatment in Patients With Motor Neuron Disease [Recruiting]
Safety and Efficacy Study of Creatine and Tamoxifen in Volunteers With Amyotrophic Lateral Sclerosis (ALS) [Completed]
A Multicenter Trial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE Inhibitors [Suspended]
Analyzing a New Mechanism in Response to Tamoxifen Therapy in Breast Cancer Patients [Recruiting]
Tamoxifen to Treat Barrett's Metaplasia [Recruiting]
Open-Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Tamoxifen When Coadministered To Healthy Post-Menopausal Female Subjects [Completed]
Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors [Recruiting]
Uterine Cavity Assessment and Endometrial Gene Expression in Tamoxifen Treated Breast Cancer Patients [Not yet recruiting]
4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ [Completed]
Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen [Terminated]
Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer [Completed]
Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients [Terminated]
Fourteen Day Safety of Low-Dose Tamoxifen in Patients With Chronic Hepatitis C Who Have Failed Standard Medical Therapy [Completed]
To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer [Active, not recruiting]
Study of Tamoxifen Dose Escalation in Breast Cancer Patients With CYP2D6 Polymorphisms [Completed]
PharmacoKINEtics of TAMoxifen and Its Metabolites in Breast Cancer Patients: the Influence of a Dose Increase in Phenotypic Poor Metabolizers of CYP2D6 (KINETAM) [Completed]
Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment [Completed]
Evaluating the Role of the Addition of Ovarian Function Suppression (OFS) to Tamoxifen in Young Women [Enrolling by invitation]
Clomiphene Citrate Versus Tamoxifen for Ovulation Induction in PCOs [Recruiting]
Trial of Concurrent Versus Sequential Tamoxifen With Radiotherapy in Breast Cancer Patients [Recruiting]
Tamoxifen Pharmacogenetics in Asian Breast Cancer Women [Recruiting]
Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen [Completed]
Cognition in the Study of Tamoxifen and Raloxifene [Completed]
Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors [Recruiting]
A Study To Determine If Coadministration Of Tamoxifen Alters The Extent Or Rate Of Palbociclib (PD-0332991) Absorption Or Elimination In Healthy Male Volunteers [Completed]
Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors [Completed]
Tamoxifen for the Treatment of Unfavorable Bleeding in Contraceptive Implant Users [Active, not recruiting]
Decision Aids for Tamoxifen Treatment in Breast Cancer Patients [Not yet recruiting]
Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer [Completed]
Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Completed]
Tamoxifen Citrate in Treating Premenopausal Women With Estrogen Receptor-Positive Breast Cancer [Recruiting]
A Trial of Tamoxifen and Letrozole in Recurrent and Persistent Squamous Cell Carcinoma of the Cervix [Recruiting]
Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen [Active, not recruiting]
CYP2D6 Genotype on the Clinical Effect of Tamoxifen [Recruiting]
Exemestane (Aromasine) + Tamoxifen - Breast Neo-Adjuvant [Completed]
Liver Safety Under Upfront Arimidex vs Tamoxifen [Completed]
Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast Cancer [Recruiting]
Lapatinib and Tamoxifen in Treating Patients With Advanced or Metastatic Breast Cancer [Active, not recruiting]
Phase III, Randomized, Double Blind Trial Low Dose Tamoxifen Versus Placebo in Hormone Replacement Therapy (HRT) Users [Active, not recruiting]
Tamoxifen Citrate in Patients With Breast Cancer [Recruiting]
Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer [Completed]
Clinical Trial to Evaluate the Safety and Effectiveness of GDC-0032 When Given Alongside Tamoxifen [Recruiting]
Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ [Active, not recruiting]
Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women. [Completed]
ATAC - Arimidex, Tamoxifen Alone or in Combination [Completed]
Effects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast Cancer [Completed]
Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor [Active, not recruiting]
The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast Cancer [Completed]
Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer [Active, not recruiting]
Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer [Active, not recruiting]
SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer [Completed]
A Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer [Terminated]
Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery [Active, not recruiting]
Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or Not [Completed]
A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6 [Recruiting]
Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer [Completed]
Tamoxifen in Treatment of Acute Mania [Completed]
A Prospective, Randomised, Multi-centre Phase II Study Evaluating the Adjuvant, Neoadjuvant or Palliative Treatmant With Tamoxifen +/- GnRH Analogue Versus Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients [Recruiting]
Randomized Study Comparing Tamoxifen Vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-Positive Patients [Completed]
CYP2D6 Genotyping by AmpliChipTM CYP450 for Tamoxifen-Treated Breast Cancer Patients [Recruiting]
Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment [Completed]
A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer [Completed]
Tamoxifen Pharmacogenetics and Clinical Effects [Completed]
Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer [Active, not recruiting]
Zoladex Plus Tamoxifen in Breast Cancer [Completed]
Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia [Active, not recruiting]
ATAC - Pharmacokinetics (PK) Sub-Protocol [Completed]
Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors [Completed]
Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer [Withdrawn]
Tamoxifen-MRI Study [Completed]
Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast Cancer [Active, not recruiting]
CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen [Recruiting]
A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy [Completed]
Tamoxifen Resistance in Women With Stage I, Stage II, Stage IIIA, or Stage IIIB Breast Cancer [Terminated]
Examination of Tamoxifen in Acute Mania in Patients With Bipolar I Disorder [Completed]
Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane [Completed]
Pilot Study About Tamoxifen Therapy for Breast Cancer Patients [Recruiting]
ATAC - Endometrial Sub-Protocol [Completed]
Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis [Active, not recruiting]
Trial of BKM120/Tamoxifen-combination in Patients With HR-pos, HER2-neg Breast Cancer [Recruiting]
Breast Cancer, Sexuality and Black Cohosh [Recruiting]
Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02 [Active, not recruiting]
German Preoperative Adriamycin Docetaxel Study [Completed]
Tamoxifen Compared With Clomiphene Citrate for Women Who Had Thin Endometrium Women Under Clomiphene in a Previous Cycle [Recruiting]
A Pilot Clinical Trial With Tocotrienol on Breast Cancer [Completed]
Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer [Completed]
A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer [Completed]
Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast Cancer [Completed]
|